Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Management.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 2 8 2022
medline: 21 1 2023
entrez: 1 8 2022
Statut: ppublish

Résumé

Accurate blood pressure (BP) measurement is critical for optimal cardiovascular risk management. Age-related trajectories for cuff-measured BP accelerate faster in women compared with men, but whether cuff BP represents the intraarterial (invasive) aortic BP is unknown. This study aimed to determine the sex differences between cuff BP, invasive aortic BP, and the difference between the 2 measurements. Upper-arm cuff BP and invasive aortic BP were measured during coronary angiography in 1615 subjects from the Invasive Blood Pressure Consortium Database. This analysis comprised 22 different cuff BP devices from 28 studies. Subjects were 64±11 years (range 40-89) and 32% women. For the same cuff systolic BP (SBP), invasive aortic SBP was 4.4 mm Hg higher in women compared with men. Cuff and invasive aortic SBP were higher in women compared with men, but the sex difference was more pronounced from invasive aortic SBP, was the lowest in younger ages, and the highest in older ages. Cuff diastolic blood pressure overestimated invasive diastolic blood pressure in both sexes. For cuff and invasive diastolic blood pressure separately, there were sex*age interactions in which diastolic blood pressure was higher in younger men and lower in older men, compared with women. Cuff pulse pressure underestimated invasive aortic pulse pressure in excess of 10 mm Hg for both sexes in older age. For the same cuff SBP, invasive aortic SBP was higher in women compared with men. How this translates to cardiovascular risk prediction needs to be determined, but women may be at higher BP-related risk than estimated by cuff measurements.

Sections du résumé

BACKGROUND
Accurate blood pressure (BP) measurement is critical for optimal cardiovascular risk management. Age-related trajectories for cuff-measured BP accelerate faster in women compared with men, but whether cuff BP represents the intraarterial (invasive) aortic BP is unknown. This study aimed to determine the sex differences between cuff BP, invasive aortic BP, and the difference between the 2 measurements.
METHODS
Upper-arm cuff BP and invasive aortic BP were measured during coronary angiography in 1615 subjects from the Invasive Blood Pressure Consortium Database. This analysis comprised 22 different cuff BP devices from 28 studies.
RESULTS
Subjects were 64±11 years (range 40-89) and 32% women. For the same cuff systolic BP (SBP), invasive aortic SBP was 4.4 mm Hg higher in women compared with men. Cuff and invasive aortic SBP were higher in women compared with men, but the sex difference was more pronounced from invasive aortic SBP, was the lowest in younger ages, and the highest in older ages. Cuff diastolic blood pressure overestimated invasive diastolic blood pressure in both sexes. For cuff and invasive diastolic blood pressure separately, there were sex*age interactions in which diastolic blood pressure was higher in younger men and lower in older men, compared with women. Cuff pulse pressure underestimated invasive aortic pulse pressure in excess of 10 mm Hg for both sexes in older age.
CONCLUSIONS
For the same cuff SBP, invasive aortic SBP was higher in women compared with men. How this translates to cardiovascular risk prediction needs to be determined, but women may be at higher BP-related risk than estimated by cuff measurements.

Identifiants

pubmed: 35912678
doi: 10.1161/HYPERTENSIONAHA.122.19693
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

316-324

Auteurs

Dean S Picone (DS)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (D.S.P., E.S., M.G.S., P.O., J.A.B., N.D.).

Elif Stoneman (E)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (D.S.P., E.S., M.G.S., P.O., J.A.B., N.D.).

Antoine Cremer (A)

Department of Cardiology/Hypertension, University Hospital of Bordeaux, France (A.C.).

Martin G Schultz (MG)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (D.S.P., E.S., M.G.S., P.O., J.A.B., N.D.).

Petr Otahal (P)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (D.S.P., E.S., M.G.S., P.O., J.A.B., N.D.).

Alun D Hughes (AD)

MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Sciences, University College London, United Kingdom (A.D.H.).

J Andrew Black (JA)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (D.S.P., E.S., M.G.S., P.O., J.A.B., N.D.).
Royal Hobart Hospital, Hobart, Australia (J.A.B., N.D.).

Willem Jan Bos (WJ)

Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands (W.J.B.).
Department of Internal Medicine, Leiden University Medical Center, The Netherlands (W.J.B.).

Chen-Huan Chen (CH)

Department of Internal Medicine, National Yang Ming Chiao Tung University College of Medicine (C.-H.C.).

Hao-Min Cheng (HM)

Department of Medicine (H.-M.C.), National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan.
Institute of Public Health (H.-M.C.), National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan.
Center for Evidence-based Medicine (H.-M.C.), Taipei Veterans General Hospital, Taiwan.
Department of Medical Education (H.-M.C.), Taipei Veterans General Hospital, Taiwan.
Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan (H.-M.C.).

Nathan Dwyer (N)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (D.S.P., E.S., M.G.S., P.O., J.A.B., N.D.).
Royal Hobart Hospital, Hobart, Australia (J.A.B., N.D.).

Peter Lacy (P)

Institute of Cardiovascular Sciences University College London (UCL) and National Institute for Health Research (NIHR) UCL/UCL Hospitals Biomedical Research Centre, United Kingdom (P.L., B.W.).

Esben Laugesen (E)

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark (E.L.).

Fuyou Liang (F)

School of Naval Architecture, Ocean and Civil Engineering, Shanghai Jiao Tong University, China (F.L.).
World-Class Research Center "Digital biodesign and personalized healthcare", Sechenov First Moscow State Medical University, Russia (F.L.).

Hack-Lyoung Kim (HL)

Division of Cardiology, Seoul National University Boramae Hospital, Seoul, South Korea (H.-L.K.).

Nobuyuki Ohte (N)

Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Japan (N.O.).

Sho Okada (S)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan (S.O.).

Stefano Omboni (S)

Clinical Research Unit, Italian Institute of Telemedicine, Varese, Italy (S.O.).
Department of Cardiology, Sechenov First Moscow State Medical University, Russian Federation (S.O.).

Christian Ott (C)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany (C.O., R.S.).

Telmo Pereira (T)

Polytechnic Institute of Coimbra, Coimbra Health School, Coimbra, Portugal (T.P.).
Laboratory for Applied Health Research (LabinSaúde), Coimbra, Portugal (T.P.).

Giacomo Pucci (G)

Unit of Internal Medicine at Terni University Hospital, Department of Medicine, University of Perugia, Italy (G.P.).

Ronak Rajani (R)

Cardiology Department, Guy's and St. Thomas' Hospitals, London, United Kingdom (R.R.).

Roland Schmieder (R)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany (C.O., R.S.).

Manish D Sinha (MD)

Kings College London British Heart Foundation Centre and Department of Clinical Pharmacology and Department of Paediatric Nephrology, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, United Kingdom (M.D.S).

Ralph Stewart (R)

Green Lane Cardiovascular Service, Auckland City Hospital, University of Auckland, New Zealand (R.S.).

George A Stouffer (GA)

Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill (G.A.S).

Kenji Takazawa (K)

Center for Health Surveillance and Preventive Medicine, Tokyo Medical University Hospital, Japan (K.T.).

Jiguang Wang (J)

Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Department of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.W.).

Thomas Weber (T)

Cardiology Department, Klinikum Wels-Grieskirchen, Austria (T.W.).

Berend E Westerhof (BE)

Department of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, The Netherlands (B.E.W.).

Bryan Williams (B)

Institute of Cardiovascular Sciences University College London (UCL) and National Institute for Health Research (NIHR) UCL/UCL Hospitals Biomedical Research Centre, United Kingdom (P.L., B.W.).

Hirotsugu Yamada (H)

Department of Community Medicine for Cardiology, Tokushima Graduate School of Biomedical Sciences, Japan (H.Y.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH